KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX)

CUSIP: 492515101

Q1 2014 13F Holders as of 31 Mar 2014

Type / Class
Equity / COMMON STOCK
Total 13F shares
67,212,223
Share change
+16,083,835
Total reported value
$1,144,703,110
Put/Call ratio
62%
Price per share
$17.04
Number of holders
149
Value change
+$286,822,120
Number of buys
89
Number of sells
55

Quarterly Holders Quick Answers

What is CUSIP 492515101?
CUSIP 492515101 identifies KERX - KERYX BIOPHARMACEUTICALS - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX) as of Q1 2014

As of 31 Mar 2014, KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX) was held by 149 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 67,212,223 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, VANGUARD GROUP INC, FMR LLC, Sectoral Asset Management Inc, FRANKLIN RESOURCES INC, WELLS FARGO & COMPANY/MN, State Street Corp, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, and OAK RIDGE INVESTMENTS LLC. This page lists 149 institutional shareholders reporting positions in this security for the Q1 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.